These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Congenital factor XI deficiency: an update. Duga S; Salomon O Semin Thromb Hemost; 2013 Sep; 39(6):621-31. PubMed ID: 23929304 [TBL] [Abstract][Full Text] [Related]
83. Allosteric modulation of exosite 1 attenuates polyphosphate-catalyzed activation of factor XI by thrombin. Yin R; Patel V; Malik RA; Fredenburgh JC; Weitz JI J Thromb Haemost; 2023 Jan; 21(1):83-93. PubMed ID: 36695400 [TBL] [Abstract][Full Text] [Related]
84. Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma. Modrzycka S; Kołt S; Adams TE; Potoczek S; Huntington JA; Kasperkiewicz P; Drąg M J Med Chem; 2023 Mar; 66(6):3785-3797. PubMed ID: 36898159 [TBL] [Abstract][Full Text] [Related]
85. Sensitivity analysis of a reduced model of thrombosis under flow: Roles of Factor IX, Factor XI, and γ'-Fibrin. Chen J; Diamond SL PLoS One; 2021; 16(11):e0260366. PubMed ID: 34813608 [TBL] [Abstract][Full Text] [Related]
87. Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro. Minami H; Nogami K; Yada K; Ogiwara K; Furukawa S; Soeda T; Kitazawa T; Shima M J Thromb Haemost; 2019 Jan; 17(1):126-137. PubMed ID: 30444568 [TBL] [Abstract][Full Text] [Related]
88. [The inherited coagulation factor XI deficiency caused by intronic mutation IVS J-4delgttg]. Xie S; Wang HL; Wang XF; Wu WM; Zhou RF; Wang WB; Hu YQ; Wang ZY Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):144-7. PubMed ID: 15946525 [TBL] [Abstract][Full Text] [Related]
89. A non-circulating pool of factor XI associated with glycosaminoglycans in mice. Mohammed BM; Cheng Q; Matafonov A; Verhamme IM; Emsley J; McCrae KR; McCarty OJT; Gruber A; Gailani D J Thromb Haemost; 2019 Sep; 17(9):1449-1460. PubMed ID: 31125187 [TBL] [Abstract][Full Text] [Related]
90. Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation. Gailani D; Broze GJ Blood; 1993 Aug; 82(3):813-9. PubMed ID: 8338946 [TBL] [Abstract][Full Text] [Related]
91. Characterization of hereditary factor XI deficiency in Taiwanese patients: identification of three novel and two common mutations. Lin HY; Lin CY; Hung MH; Kuo SF; Lin JS; Shen MC Int J Hematol; 2020 Aug; 112(2):169-175. PubMed ID: 32333264 [TBL] [Abstract][Full Text] [Related]
92. [Identification of compound heterozygous mutations p.Gly400Val and p.Arg532Ter of the F11 gene in a Chinese patient with hereditary factor XI deficiency]. Shu K; Xu K; Li F; Chen T; Liu J; Jin S; Guo J; Zhang Z; Jiang M Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):522-526. PubMed ID: 30098248 [TBL] [Abstract][Full Text] [Related]
93. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381 [TBL] [Abstract][Full Text] [Related]
94. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk. Rugeri L; Quélin F; Chatard B; De Mazancourt P; Negrier C; Dargaud Y Haemophilia; 2010 Sep; 16(5):771-7. PubMed ID: 20398070 [TBL] [Abstract][Full Text] [Related]
95. Activated Factor XI is Increased in Plasma in Response to Surgical Trauma but not to Recombinant Activated FVII-Induced Thrombin Formation. Rühl H; Friemann AM; Reda S; Schwarz N; Winterhagen FI; Berens C; Müller J; Oldenburg J; Pötzsch B J Atheroscler Thromb; 2022 Jan; 29(1):82-98. PubMed ID: 33298665 [TBL] [Abstract][Full Text] [Related]
96. Genetic analysis of a pedigree with hereditary coagulation factor XI deficiency. Zhou X; Zhang H; Wang M; Luo S; Liu S; Jin Y; Li X; Yang L Blood Coagul Fibrinolysis; 2019 Dec; 30(8):413-418. PubMed ID: 31567266 [TBL] [Abstract][Full Text] [Related]
97. Factor XI deficiency database: an interactive web database of mutations, phenotypes, and structural analysis tools. Saunders RE; O'Connell NM; Lee CA; Perry DJ; Perkins SJ Hum Mutat; 2005 Sep; 26(3):192-8. PubMed ID: 16086308 [TBL] [Abstract][Full Text] [Related]
98. Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI. Puy C; Tucker EI; Ivanov IS; Gailani D; Smith SA; Morrissey JH; Gruber A; McCarty OJ PLoS One; 2016; 11(10):e0165172. PubMed ID: 27764259 [TBL] [Abstract][Full Text] [Related]
99. Four novel FXI gene mutations in three factor XI- deficient patients. de Raucourt E; de Mazancourt P; Quélin F Blood Coagul Fibrinolysis; 2008 Apr; 19(3):240-2. PubMed ID: 18388506 [TBL] [Abstract][Full Text] [Related]
100. Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery. Yamashita A; Nishihira K; Kitazawa T; Yoshihashi K; Soeda T; Esaki K; Imamura T; Hattori K; Asada Y J Thromb Haemost; 2006 Jul; 4(7):1496-501. PubMed ID: 16839345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]